Concepedia

S. Postel-Vinay

SP

Statistics

Publications

2

Citations

98

H-Index

2

Active since

2016

Affiliations

University of Pennsylvania(Current)

S. Postel-Vinay is an author at University of Pennsylvania specializing in cancer therapeutics, radiation oncology, and medicine.

Top concepts

Publications per year

2016–2019

2

Publications

2

Phase II study of olaparib (O) and durvalumab (D) (MEDIOLA): Updated results in patients (pts) with germline BRCA-mutated (gBRCAm) metastatic breast cancer (MBC)

Susan M. Domchek, S. Postel-Vinay, S.-A. Im et al. · Annals of Oncology · 2019 · 50 citations · Full text

, , +10

Phase I modular study of AZD6738, a novel oral, potent and selective ataxia telangiectasia Rad3-related (ATR) inhibitor in combination (combo) with carboplatin, olaparib or durvalumab in patients (pts) with advanced cancers

Timothy A. Yap, Matthew Krebs, S. Postel-Vinay et al. · European Journal of Cancer · 2016 · 48 citations

, , +7

1–2 of 2